Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of FLRT3 mRNA | increases expression | 19933214
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of FLRT3 protein | affects expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FLRT3 mRNA | increases expression | 20382639
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of FLRT3 mRNA | decreases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of FLRT3 mRNA | increases expression | 16002434
|
D008942 |
Mitoxantrone |
FLRT3 protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FLRT3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D012402 |
Rotenone |
Rotenone results in decreased expression of FLRT3 mRNA | decreases expression | 19013527
|
D012643 |
Selenium |
Selenium results in decreased expression of FLRT3 mRNA | decreases expression | 19244175
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of FLRT3 mRNA | increases expression | 19933214
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of FLRT3 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.04 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.27 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.56 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.56 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.08 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.24 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.24 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.01 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.85 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.09 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.11 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.91 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
1.97 | 21507988 12619106 12907637 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.66 | 11237771 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.44 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.87 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.87 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.10 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.10 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.15 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003092 |
Colitis |
|
Selenium |
3.95 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.52 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.52 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.48 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
3.89 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.89 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.86 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.92 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.00 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.00 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.12 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.09 | 15138306 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.15 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.03 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.03 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.63 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.07 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.07 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.41 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.81 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.80 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.80 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.24 | 16019553 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.22 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.22 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.62 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.48 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.85 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.85 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.74 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.19 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.26 | 18606429 8697196 16959395 15340226 16354765 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.31 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.10 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.10 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.92 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.70 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.70 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.72 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.48 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.66 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.27 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.27 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.02 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.85 | 12371664 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.84 | 18172266 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.49 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.49 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.49 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
7.63 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.63 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.63 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.08 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.08 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.27 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.48 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.48 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.48 | 11062179 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.85 | 15318939 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.84 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.01 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.68 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.19 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.13 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.05 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.49 | 16640825 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.49 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.66 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.41 | 19348381 18481113 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.99 | 15790535 17356569 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.37 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.02 | 15451049 16412576 11445065 18619942 19114014 16140633 11535288 18191903 19232380 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.21 | 15927086 15574749 15795934 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.47 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.11 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.72 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.35 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.38 | 11896295 11118676 11399792 11222880 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.97 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.37 | 16644109 18247401 15754350 16289102 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.37 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.27 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.45 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.00 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.47 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.10 | 16192470 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.63 | 16517955 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.12 | 12697716 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.20 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.81 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.47 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.66 | 17120751 |